JP7744641B2 - 肺癌における自己抗体を検出するための抗原の組合せの使用 - Google Patents

肺癌における自己抗体を検出するための抗原の組合せの使用

Info

Publication number
JP7744641B2
JP7744641B2 JP2023502699A JP2023502699A JP7744641B2 JP 7744641 B2 JP7744641 B2 JP 7744641B2 JP 2023502699 A JP2023502699 A JP 2023502699A JP 2023502699 A JP2023502699 A JP 2023502699A JP 7744641 B2 JP7744641 B2 JP 7744641B2
Authority
JP
Japan
Prior art keywords
ssx1
hud
koc
sox2
tumor marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023502699A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022013321A5 (enExample
JP2023533815A (ja
Inventor
マーレイ アンドレア
アレン ジャレド
ガニング フィリップ
マクドナルド イザベル
パーシー‐コワルスカ セリーヌ
Original Assignee
フリーノム リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN202010677754.6A external-priority patent/CN113933509A/zh
Priority claimed from GB2017434.8A external-priority patent/GB2600701A/en
Application filed by フリーノム リミテッド filed Critical フリーノム リミテッド
Publication of JP2023533815A publication Critical patent/JP2023533815A/ja
Publication of JPWO2022013321A5 publication Critical patent/JPWO2022013321A5/ja
Application granted granted Critical
Publication of JP7744641B2 publication Critical patent/JP7744641B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4748—Details p53
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2023502699A 2020-07-14 2021-07-14 肺癌における自己抗体を検出するための抗原の組合せの使用 Active JP7744641B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202010677754.6A CN113933509A (zh) 2020-07-14 2020-07-14 抗体测定
CN202010677754.6 2020-07-14
GB2017434.8 2020-11-04
GB2017434.8A GB2600701A (en) 2020-11-04 2020-11-04 Antibody assay
PCT/EP2021/069668 WO2022013321A2 (en) 2020-07-14 2021-07-14 Antibody assay

Publications (3)

Publication Number Publication Date
JP2023533815A JP2023533815A (ja) 2023-08-04
JPWO2022013321A5 JPWO2022013321A5 (enExample) 2024-07-25
JP7744641B2 true JP7744641B2 (ja) 2025-09-26

Family

ID=76971915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023502699A Active JP7744641B2 (ja) 2020-07-14 2021-07-14 肺癌における自己抗体を検出するための抗原の組合せの使用

Country Status (6)

Country Link
US (1) US20230266331A1 (enExample)
EP (1) EP4182693A2 (enExample)
JP (1) JP7744641B2 (enExample)
KR (1) KR20230068378A (enExample)
CN (1) CN116324412A (enExample)
WO (1) WO2022013321A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024197052A1 (en) * 2023-03-20 2024-09-26 Rush University Medical Center Circulating autoantibody biomarkers to supplement lung cancer screening

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010532480A (ja) 2007-06-29 2010-10-07 アボット・ラボラトリーズ 肺癌に対する素因をスクリーニングするための方法およびマーカーの組み合わせ
CN103869086A (zh) 2014-04-14 2014-06-18 杭州凯保罗生物科技有限公司 一种血清自身抗体检测试剂盒
US20170138951A1 (en) 2014-06-20 2017-05-18 Oncimmune Limited Immunoassay methods
CN110716050A (zh) 2019-11-13 2020-01-21 基因科技（上海）股份有限公司 抗原组合在制备用于肺癌相关自身抗体检测的试剂盒中的用途以及相应的试剂盒和检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB2424070B (en) 2002-11-14 2007-06-27 Univ Nottingham Methods for preparing tumour marker proteins
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
US20100204055A1 (en) * 2008-12-05 2010-08-12 Bonner-Ferraby Phoebe W Autoantibody detection systems and methods
CN103383395B (zh) * 2013-07-10 2015-09-09 杭州市第一人民医院 一种用于检测肺癌自身抗体的液相芯片试剂盒

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010532480A (ja) 2007-06-29 2010-10-07 アボット・ラボラトリーズ 肺癌に対する素因をスクリーニングするための方法およびマーカーの組み合わせ
CN103869086A (zh) 2014-04-14 2014-06-18 杭州凯保罗生物科技有限公司 一种血清自身抗体检测试剂盒
US20170138951A1 (en) 2014-06-20 2017-05-18 Oncimmune Limited Immunoassay methods
CN110716050A (zh) 2019-11-13 2020-01-21 基因科技（上海）股份有限公司 抗原组合在制备用于肺癌相关自身抗体检测的试剂盒中的用途以及相应的试剂盒和检测方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J． JETT et al.，P2.13-013 Determination of the Detection Lead Time for Autoantibody Biomarkers in Early Stage Lung Cancer Using the UKCTOCS Cohort，Journal of Thoracic Oncology，2017年11月，Vol.12, No.11，p.S2170，DOI: 10.1016/j.jtho.2017.09.1360

Also Published As

Publication number Publication date
WO2022013321A2 (en) 2022-01-20
EP4182693A2 (en) 2023-05-24
WO2022013321A3 (en) 2022-03-10
CN116324412A (zh) 2023-06-23
KR20230068378A (ko) 2023-05-17
US20230266331A1 (en) 2023-08-24
JP2023533815A (ja) 2023-08-04

Similar Documents

Publication Publication Date Title
CN111337678B (zh) 与肿瘤免疫治疗效果相关的生物标志物及其应用
EP2275815B1 (en) Improved immunoassay methods
CN101632020B (zh) 改进的免疫测定方法
JP5736598B2 (ja) 改善されたイムノアッセイ法
US20110201517A1 (en) Autoantigen biomarkers for early diagnosis of lung adenocarcinoma
CN108107218B (zh) 抗体测定
US20100204055A1 (en) Autoantibody detection systems and methods
WO2008061104A2 (en) Methods and kits for detecting prostate cancer biomarkers
KR20120098992A (ko) 암의 검출을 위한 방법 및 시스템
CN115877006B (zh) 卵巢癌相关的生物标志物及其应用
JP7744641B2 (ja) 肺癌における自己抗体を検出するための抗原の組合せの使用
NO342101B1 (no) In vitro fremgangsmåte for bestemmelse av antistoffprofil i en testprøve samt anvendelse av fremgangsmåten i diagnose, prognose eller overvåkningen av kreft
CN103257227B (zh) 改进的免疫测定方法
CN116539885B (zh) 用于乳腺癌早期检测的肿瘤自身抗原/抗体组合及应用
CN113933509A (zh) 抗体测定
GB2600701A (en) Antibody assay
TW201928351A (zh) 抗體測定
HK1152565A (en) Improved immunoassay methods
HK1152565B (en) Improved immunoassay methods

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230526

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240712

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240712

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250409

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250507

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250729

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250812

RD13 Notification of appointment of power of sub attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7433

Effective date: 20250825

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250903

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20250825

R150 Certificate of patent or registration of utility model

Ref document number: 7744641

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150